Piper Sandler raised the price target for the Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) stock from “an Overweight” to “a Neutral”. The rating was released on February 01, 2023, according to finviz. The research report from Goldman has upgraded the stock from Neutral to Buy, with a price target set at $23. The stock was resumed by Piper Sandler, who disclosed in a research note on November 04, 2022, to Overweight and set the price objective to $17.
The latest trade, Performances and Moving Averages give us the following Picture
The share price of Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) raised 0.15% to close Thursday’s market session at $13.41, higher as compared to yesterday’s close. The stock price fluctuated between $13.07 and $13.66 throughout the trading session with the volume trading being 1387131 shares, which represented a significant variation when compared to the three months average volume of 1.17 million shares. The firm’s stock price fluctuated -5.50% within the last five trades and -23.50% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price decreased -18.78% in the last 6 months and -28.29% was subtracted to its value over the previous 3 months. MDRX stock is trading at a margin of -13.62%, -20.84% and -18.92% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
As of the close of trading, MDRX deals in the Healthcare domain. The stock is trading -42.32 percent below its 52-week high and 2.44 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is -39.5. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.
What Does Allscripts Healthcare Solutions Inc.’s Profitability and Valuation Ratios Tell Us About the Stock?
With regard to the profitability of the company, the operating margin is currently at 8.10 percent and the profit margin is 7.20 percent, and the company has reported a gross margin of 48.40 percent. The profit margin, also known as the revenue ratio or gross profit ratio, is an efficiency figure used to estimate the business’s profitability by comparing net income and sales. The higher the number, the more profits are generated for the company and vice versa.
The stock’s market cap achieved a total value of $1.50 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. The price-to-earnings ratio for Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) is 14.25. The price-to-earnings ratio is a method of assessing corporate values by comparing them to their per-share profit. Forward P/E stands at 14.64. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 1.79 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 1.26, which equates the market value of a stock with its book value.
Is Insider Trading a Real Thing?
Poulton Richard J., the CEO at Allscripts Healthcare Solutions Inc. (MDRX) has sold 10,000 shares of firm on Feb 16 at a price of $17.33 against the total amount of $0.17 million. In another inside trade, Poulton Richard J., CEO of Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) sold 10,000 shares of the firm on Feb 15 for a total worth of $0.17 million at a price of $17.38. An inside trade which took place on Dec 12, SVP General Counsel of Allscripts Healthcare Solutions Inc. Vakharia Tejal sold 8,642 shares of firm against total price of $0.16 million at the cost of $18.42 per share.